SCHEMBL18784245

SCHEMBL18784245

NCCNc1c(CS(=O)(=O)c2ccccc2)cccc1-c1ccoc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAT1 P18440 3/20 0.39
PTGES2 Q9H7Z7 1/20 0.36
ALOX5AP P20292 1/20 0.35
MCL1 Q07820 1/20 0.32
ALDH1A1 P00352 3/20 0.32
HSD17B10 Q99714 3/20 0.32
TSHR P16473 2/20 0.32
CYP1A2 P05177 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2D6 P10635 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32
CLK4 Q9HAZ1 1/20 0.32
RECQL P46063 1/20 0.32
CSNK2A1 P68400 1/20 0.31
PLAU P00749 1/20 0.31
ADORA2A P29274 1/20 0.31
NPC1 O15118 3/20 0.31
RAB9A P51151 3/20 0.31
TDP1 Q9NUW8 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1647973 0.85 NAT1 (0.36) NAT1PTGES2ALOX5APMCL1HSD17B10
SCHEMBL14725678 0.85 NAT1 (0.36) NAT1PTGES2ALOX5APMCL1HSD17B10
Hydrochloric Acid SCHEMBL1648354 0.79 NAT1 (0.33) NAT1HSD17B10TSHRSMN1; SMN2MAPT
SCHEMBL18784244 0.77 CSNK2A1 (0.40) NAT1PTGES2ALOX5APALDH1A1HSD17B10
SCHEMBL18784224 0.77 ALOX5AP (0.37) NAT1PTGES2ALOX5APMCL1ALDH1A1
SCHEMBL1648374 0.72 METAP2 (0.40) NAT1PTGES2ALOX5APMCL1ALDH1A1
Hydrochloric Acid SCHEMBL1648037 0.72 NAT1 (0.34) NAT1PTGES2ALOX5APMCL1ALDH1A1
SCHEMBL14725681 0.71 NAT1 (0.35) NAT1PTGES2ALOX5APMCL1ALDH1A1
Hydrochloric Acid SCHEMBL1648362 0.71 METAP2 (0.39) NAT1ALOX5APMCL1HSD17B10TSHR
Hydrochloric Acid SCHEMBL1648336 0.71 METAP2 (0.39) NAT1ALOX5APMCL1HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2486004-B1 SULPHONE COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY ZAFGEN INC (US) 2017-05-03 EP claimed